Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Feasibility Study of 'SuperBrain BOOM' for Mild Cognitive Impairment Patients

NCT: NCT07101380 · RECRUITING

NCT IDNCT07101380
StatusRECRUITING
Start Date2026-02-23
Completion2026-07-31

Brief Summary

The goal of this clinical trial is to learn whether a mobile-based personalized physical activity program called SuperBrain BOOM is safe and works to improve cognitive function, physical performance, mood, and quality of life in older adults (ages 50-85) with mild cognitive impairment (MCI). The main questions it aims to answer are: Can SuperBrain BOOM be safely and effectively used by people with MCI? Does the program help improve cognitive and physical function? Do participants stay engaged and complete the program as expected? Researchers will compare: A mobile intervention group using SuperBrain BOOM (on tablet or smartphone) A control group receiving usual care Participants will: Use a tablet or smartphone to follow a personalized physical activity program for 12 weeks Complete clinical assessments on cognition, physical ability, mood, and nutrition Be monitored for safety and program adherence using automatically collected data

Frequently Asked Questions

What is Feasibility Study of 'SuperBrain BOOM' for Mild Cognitive Impairment Patients?

Feasibility Study of 'SuperBrain BOOM' for Mild Cognitive Impairment Patients is a clinical trial registered under NCT07101380. Current status: RECRUITING.

What is the status of NCT07101380?

The current status of NCT07101380 (Feasibility Study of 'SuperBrain BOOM' for Mild Cognitive Impairment Patients) is: RECRUITING.

When did Feasibility Study of 'SuperBrain BOOM' for Mild Cognitive Impairment Patients start?

Feasibility Study of 'SuperBrain BOOM' for Mild Cognitive Impairment Patients started on 2026-02-23.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.